Date: 01 Feb 2012
Direct-to-Consumer Personal Genomic Testing: A Case Study and Practical Recommendations for “Genomic Counseling”
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Technological advances and information-seeking consumers have pushed forward the movement of direct-to-consumer (DTC) genetic testing. Just like with other types of testing, there are potential risks, benefits and limitations. A major limitation of DTC testing is the incomplete view it provides regarding lifetime risk for common, complex diseases, since most tests only analyze 1–2 single nucleotide polymorphisms (SNPs) and do not include evaluation of medical or family histories, which is necessary to risk assessment. Further, it is not currently well-established whether personal genomic testing results will lead toward improved health behaviors, adverse psychological effects or potential overuse of the health care system. To display these and other issues, we present an in-depth case study of an individual who ordered DTC genetic testing and subsequently sought genetic counseling. This case presents a unique learning experience for the field of genomic counseling, as the patient did not fit the typical assumptions regarding ‘early adopters’ of DTC testing. It also allowed the genetics health care providers involved in the case to identify gaps in current genetic counseling practice that need to be filled and approaches to employ for successful delivery of genomic counseling. Based on our experience, we developed practical recommendations for genomic counseling, which include novel approaches to case preparation, use of electronic tools during the counseling session, and focusing on education as the major component of the genomic counseling session, in order to provide patients with the knowledge necessary to independently interpret and understand large amounts of genomic testing information provided to them.
Bowen, D. J., Battuello, K. M., & Raats, M. (2005). Marketing genetic tests: empowerment or snake oil? Health Education & Behavior, 32(5), 676–685.CrossRef
Dhillon, P. K., Farrow, D. C., Vaughan, T. L., Chow, W. H., Risch, H. A., Gammon, M. D., et al. (2001). Family history of cancer and risk of esophageal and gastric cancers in the United States. International Journal of Cancer, 93(1), 148–152.CrossRef
DTC Genetic Testing Companies Compiled by the Genetics and Public Policy Center. (2011). Retrieved September 2, 2011, from http://www.dnapolicy.org/resources/DTCTableAug2011Alphabydisease.pdf.
Hamajima, N., Atsuta, Y., Goto, Y., & Ito, H. (2004). A pilot study on genotype announcement to induce smoking cessation by Japanese smokers. Asian Pacific Journal of Cancer Prevention, 5(4), 409–413.PubMed
Lagergren, J., Ye, W., Lindgren, A., & Nyren, O. (2000). Heredity and risk of cancer of the esophagus and gastric cardia. Cancer Epidemiology, Biomarkers & Prevention, 9(7), 757–760.
Lerman, C., Gold, K., Audrain, J., Lin, T. H., Boyd, N. R., Orleans, C. T., et al. (1997). Incorporating biomarkers of exposure and genetic susceptibility into smoking cessation treatment: effects on smoking-related cognitions, emotions, and behavior change. Health Psychology, 16(1), 87–99.PubMedCrossRef
McBride, C. M., Bepler, G., Lipkus, I. M., Lyna, P., Samsa, G., Albright, J., et al. (2002). Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. Cancer Epidemiology, Biomarkers & Prevention, 11(6), 521–528.
Soskolne, C. L., & Sieswerda, L. E. (2010). Cancer risk associated with pulp and paper mills: a review of occupational and community epidemiology. Chronic Diseases in Canada, 29(Suppl 2), 86–100.PubMed
- Direct-to-Consumer Personal Genomic Testing: A Case Study and Practical Recommendations for “Genomic Counseling”
Journal of Genetic Counseling
Volume 21, Issue 3 , pp 402-412
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Genomic counseling
- Direct-to-consumer genetic testing
- Personal genomics
- Family history
- Risk assessment
- Industry Sectors
- Author Affiliations
- 1. Division of Human Genetics, Department of Internal Medicine, The Ohio State University Medical Center, Columbus, OH, USA
- 2. Center for Personalized Health Care, The Ohio State University Medical Center, Columbus, OH, USA
- 4. Division of Human Genetics, Center for Personalized Health Care, The Ohio State University Medical Center, 2001 Polaris Parkway, Columbus, OH, 43240, USA
- 3. Center for Molecular and Human Genetics, Nationwide Children’s Hospital, Columbus, OH, USA